# J. Gene Wang, MD, PhD

> J. Gene Wang is co-founder and CEO of Immetas Therapeutics, which he launched with David Sinclair in 2018 after roughly twenty years at Merck, Abbott, GSK and Novartis. He holds an MD from Peking University and a PhD from Yale. Immetas announced an $11 million Series A from Morningside Ventures in 2020 and a research collaboration with GC Biopharma in 2023. Yale Ventures lists him in its entrepreneurial network; its 2026 report names his involvement with Artelis.

- **Role:** Co-Founder & CEO at Immetas Therapeutics
- **Organizations:** Immetas Therapeutics, Yale Ventures, Merck, Abbott, GSK, Novartis
- **Education:** MD, Peking University Medical Center, PhD in Immunobiology, Yale University
- **Known for:** Co-founded Immetas Therapeutics with David Sinclair., Led development strategies and cross-functional teams at major companies., Immetas secured an $11 million Series A in 2020.

## Career timeline

- **Before 2018** — Approximately twenty-year corporate career spanning Merck, Abbott, GSK and Novartis, including development strategy and leadership of cross-functional teams.
- **2018-10** — Launched Immetas Therapeutics with David Sinclair.
- **2020-09** — Immetas announced an $11 million Series A, with Morningside Ventures as sole investor; Lu Huang joined the board.
- **2023-10** — Immetas announced a research collaboration with South Korea-based GC Biopharma.
- **2026** — Yale Ventures annual report identified Gene Wang with Artelis as an example of an entrepreneur in residence moving from advising into operating.

## Achievements

- Co-founded Immetas Therapeutics with David Sinclair.
- Led development strategies and cross-functional teams at major companies.
- Immetas secured an $11 million Series A in 2020.
- Immetas entered a research collaboration with GC Biopharma in 2023.

## Latest updates

- **2026-06** — Yale Ventures FY2026 report names Gene Wang with Artelis in its discussion of the pathway from entrepreneur-in-residence advisor to operator; it does not specify his title or start date.
- **2023-10** — Immetas and GC Biopharma announced a research collaboration on October 12, 2023.

## Links

- Website: https://immetas.com/
- LinkedIn: https://www.linkedin.com/in/j-gene-wang-m-d-ph-d-2856045

---

Profile page: https://yespress.io/j-gene-wang
Published by YesPress — https://yespress.io
Last updated: 2026-10-11